Form 8-K - Current report:
SEC Accession No. 0001171843-25-004062
Filing Date
2025-06-24
Accepted
2025-06-24 17:01:26
Documents
13
Period of Report
2025-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_062425.htm   iXBRL 8-K 34268
2 EXHIBIT 10.1 exh_101.htm EX-10.1 169521
  Complete submission text file 0001171843-25-004062.txt   406553

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE anik-20250620.xsd EX-101.SCH 3029
4 XBRL LABEL FILE anik-20250620_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE anik-20250620_pre.xml EX-101.PRE 22368
15 EXTRACTED XBRL INSTANCE DOCUMENT f8k_062425_htm.xml XML 3562
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 251069995
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)